Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,966,469
- Total 13F shares
- 88,392,782
- Share change
- +11,843,775
- Total reported value
- $1,743,047,001
- Put/Call ratio
- 25%
- Price per share
- $19.72
- Number of holders
- 133
- Value change
- +$233,806,685
- Number of buys
- 94
- Number of sells
- 34
Quarterly Holders Quick Answers
What is CUSIP 76155X100?
CUSIP 76155X100 identifies RVMD - Revolution Medicines, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76155X100:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Third Rock Ventures III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,104,130
|
$137,811,510 | — | 08 Jun 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
6,169,002
|
$120,233,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
5,567,012
|
$108,502,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
5,403,804
|
$105,319,000 | — | 30 Jun 2022 | |
| TRV GP III, LLC |
13F
|
Company |
2.6%
|
5,104,130
|
$99,479,000 | — | 30 Jun 2022 | |
| Column Group LLC |
13F
|
Company |
2.3%
|
4,395,050
|
$85,660,000 | — | 30 Jun 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.2%
|
4,278,069
|
$83,380,000 | — | 30 Jun 2022 | |
| Nextech Invest Ltd. |
13F
|
Company |
2%
|
3,939,529
|
$76,781,000 | — | 30 Jun 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
3,484,264
|
$67,908,000 | — | 30 Jun 2022 | |
| Bellevue Group AG |
13F
|
Company |
1.8%
|
3,383,262
|
$65,940,000 | — | 30 Jun 2022 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
3,250,000
|
$63,343,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
3,094,982
|
$60,321,000 | — | 30 Jun 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
1.2%
|
2,370,000
|
$46,191,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
1.2%
|
2,255,588
|
$43,961,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
2,237,854
|
$43,616,000 | — | 30 Jun 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1%
|
1,995,066
|
$38,884,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.96%
|
1,852,852
|
$36,112,000 | — | 30 Jun 2022 | |
| TRV GP IV, LLC |
13F
|
Company |
0.74%
|
1,419,900
|
$27,674,000 | — | 30 Jun 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
0.69%
|
1,325,000
|
$25,824,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
1,165,758
|
$22,720,000 | — | 30 Jun 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.52%
|
1,001,308
|
$19,500,000 | — | 30 Jun 2022 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.46%
|
891,587
|
$17,377,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.46%
|
889,497
|
$17,336,000 | — | 30 Jun 2022 | |
| Ponoi II Management, LLC |
13F
|
Company |
0.35%
|
685,011
|
$13,351,000 | — | 30 Jun 2022 | |
| Ponoi Management, LLC |
13F
|
Company |
0.35%
|
685,011
|
$13,351,000 | — | 30 Jun 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.35%
|
670,382
|
$13,066,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.33%
|
639,164
|
$12,457,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
630,697
|
$12,291,000 | — | 30 Jun 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.29%
|
555,237
|
$10,821,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.25%
|
492,007
|
$9,589,216 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
444,403
|
$8,662,000 | — | 30 Jun 2022 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.23%
|
438,054
|
$8,538,000 | — | 30 Jun 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.18%
|
349,500
|
$6,812,000 | — | 30 Jun 2022 | |
| 53 HOUSE LLP |
13F
|
Company |
0.18%
|
344,324
|
$6,711,000 | — | 30 Jun 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.16%
|
299,785
|
$5,843,000 | — | 30 Jun 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.14%
|
263,799
|
$5,141,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.13%
|
255,443
|
$4,979,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
242,030
|
$4,718,000 | — | 30 Jun 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.12%
|
222,222
|
$4,331,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
211,492
|
$4,122,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
197,996
|
$3,859,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
197,297
|
$3,845,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
197,060
|
$3,841,000 | — | 30 Jun 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
0.08%
|
148,453
|
$2,893,000 | — | 30 Jun 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.08%
|
146,041
|
$2,846,000 | — | 30 Jun 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
112,134
|
$2,185,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
109,530
|
$2,135,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
107,200
|
$2,089,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
105,456
|
$2,055,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
104,200
|
$2,031,000 | — | 30 Jun 2022 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2022
As of 30 Sep 2022,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,392,782 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, Column Group LLC, STATE STREET CORP, Nextech Invest AG, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and TRV GP III, LLC.
This page lists
133
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
125
Q3 2022 holders
133
Holder diff
8
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.